Viemed Healthcare Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017
Cash & Equivalents	12.84	16.91	28.41	30.98	13.36	10.41	5.1
Cash & Cash Equivalents	12.84	16.91	28.41	30.98	13.36	10.41	5.1
Cash Growth	-24.09%	-40.46%	-8.31%	131.98%	28.25%	104.26%	-
Receivables	18.45	15.38	12.82	12.37	11.53	8.84	9.78
Inventory	4.63	3.57	2.46	2.31	1.36	2.89	1.63
Other Current Assets	2.45	3.88	3.62	1.51	1.56	0.95	0.49
Total Current Assets	38.37	39.74	47.31	47.18	27.81	23.09	17
Property, Plant & Equipment	76.85	68.44	62.85	55.06	54.77	30.56	20.69
Long-Term Investments	3.9	4.16	2.16	0.73	0.01	0	0
Goodwill and Intangibles	30.33	0	0	0	0	0	0
Other Long-Term Assets	5.45	4.71	5.65	9.6	0	0	0
Total Long-Term Assets	116.53	77.3	70.65	65.39	54.79	30.56	20.69
Total Assets	154.9	117.04	117.96	112.56	82.6	53.65	37.69
Accounts Payable	4.18	2.65	3.24	2.1	4.7	5.88	3.39
Deferred Revenue	6.21	4.62	3.75	3.41	3.32	2.59	0
Current Debt	2.01	0.5	1.94	4.58	8.84	3.03	4.38
Other Current Liabilities	19.73	11.09	8.88	12.94	9.05	8.07	5.38
Total Current Liabilities	32.12	18.86	17.81	23.02	25.91	19.57	13.15
Long-Term Debt	8.32	0.2	4.57	6.56	10.67	0.39	0.8
Other Long-Term Liabilities	0.56	0.89	0.76	1.29	2.32	1.12	0
Total Long-Term Liabilities	8.88	1.09	5.33	7.85	12.99	1.51	0.8
Total Liabilities	41	19.95	23.14	30.87	38.9	21.08	13.95
Total Debt	10.32	0.69	6.52	11.14	19.51	3.43	5.18
Debt Growth	1387.61%	-89.35%	-41.46%	-42.93%	469.66%	-33.87%	-
Retained Earnings	79.5	69.85	73.34	65.64	34.11	27.11	20.99
Comprehensive Income	0	0	-0.28	-0.45	-0.16	0	0
Shareholders' Equity	113.9	97.09	94.82	81.69	43.7	32.57	23.74
Net Cash / Debt	2.52	16.22	21.89	19.85	-6.16	6.99	-0.08
Net Cash / Debt Growth	-84.49%	-25.90%	10.30%	-	-	-	-
Net Cash Per Share	0.06	0.41	0.54	0.49	-0.15	0.18	-0.00
Working Capital	6.24	20.88	29.5	24.16	1.9	3.52	3.85
Book Value Per Share	2.97	2.51	2.40	2.11	1.16	0.86	0.63

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).